Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faleh Alqahtani

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
International Journal of Molecular Sciences|October 29, 2025
The Tumor Suppressor p53 Downregulates p107 (<i>RBL1</i>) Through p21-RB/E2F Signaling and Tandem E2F SitesKhaled Azzahrani, Faleh Alqahtani
Journal of Cellular and Molecular Medicine|June 23, 2021
Impact of chronic smoking on traumatic brain microvascular injury: An in vitro studyFarzane Sivandzade, Faleh Alqahtani, Luca Cucullo
International Journal of Molecular Sciences|April 17, 2020
Traumatic Brain Injury and Blood-Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid ConditionFarzane Sivandzade, Faleh Alqahtani, Luca Cucullo
Expert Opinion on Drug Metabolism & Toxicology|January 25, 2024
Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing modelsAmmara Zamir, Faleh Alqahtani, Muhammad Fawad Rasool
Journal of Neuroinflammation|April 29, 2020
The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo studyFarzane Sivandzade, Faleh Alqahtani, Ali Sifat, et al.
Healthcare (Basel, Switzerland)|September 28, 2024
The Economic Burden of Type 2 Diabetes Mellitus in Pakistan: A Cost of Illness StudyMuhammad Subhan Arshad, Faleh Alqahtani, Muhammad Fawad Rasool
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 6, 2024
A Systematic Review of the Economic Burden of Diabetes in Eastern Mediterranean Region CountriesMuhammad Subhan Arshad, Faleh Alqahtani, Muhammad Fawad Rasool
Drug Metabolism Reviews|May 6, 2026
Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic reviewTahir Saleem, Muhammad Fawad Rasool, Hamid Saeed, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Exploring the Pharmacokinetics of Drugs in Disabled Saudi Patients: A Systematic ReviewFaleh Alqahtani, Saeed A Al Awadh, Muhammad Fawad Rasool
Pharmaceutics|January 8, 2025
Model-Based Dose Selection of a Sphingosine-1-Phosphate Modulator, Etrasimod, in Patients with Various Degrees of Hepatic ImpairmentMohammed S Alasmari, Faleh Alqahtani, Fawaz Alasmari, et al.
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
International Journal of Molecular Sciences|October 29, 2025
The Tumor Suppressor p53 Downregulates p107 (<i>RBL1</i>) Through p21-RB/E2F Signaling and Tandem E2F SitesKhaled Azzahrani, Faleh Alqahtani
Journal of Cellular and Molecular Medicine|June 23, 2021
Impact of chronic smoking on traumatic brain microvascular injury: An in vitro studyFarzane Sivandzade, Faleh Alqahtani, Luca Cucullo
International Journal of Molecular Sciences|April 17, 2020
Traumatic Brain Injury and Blood-Brain Barrier (BBB): Underlying Pathophysiological Mechanisms and the Influence of Cigarette Smoking as a Premorbid ConditionFarzane Sivandzade, Faleh Alqahtani, Luca Cucullo
Expert Opinion on Drug Metabolism & Toxicology|January 25, 2024
Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing modelsAmmara Zamir, Faleh Alqahtani, Muhammad Fawad Rasool
Journal of Neuroinflammation|April 29, 2020
The cerebrovascular and neurological impact of chronic smoking on post-traumatic brain injury outcome and recovery: an in vivo studyFarzane Sivandzade, Faleh Alqahtani, Ali Sifat, et al.
Healthcare (Basel, Switzerland)|September 28, 2024
The Economic Burden of Type 2 Diabetes Mellitus in Pakistan: A Cost of Illness StudyMuhammad Subhan Arshad, Faleh Alqahtani, Muhammad Fawad Rasool
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|February 6, 2024
A Systematic Review of the Economic Burden of Diabetes in Eastern Mediterranean Region CountriesMuhammad Subhan Arshad, Faleh Alqahtani, Muhammad Fawad Rasool
Drug Metabolism Reviews|May 6, 2026
Exploring the clinical pharmacokinetics and pharmacodynamics of SGLT2 inhibitor, empagliflozin: a systematic reviewTahir Saleem, Muhammad Fawad Rasool, Hamid Saeed, et al.
Pharmaceuticals (Basel, Switzerland)|April 26, 2025
Exploring the Pharmacokinetics of Drugs in Disabled Saudi Patients: A Systematic ReviewFaleh Alqahtani, Saeed A Al Awadh, Muhammad Fawad Rasool
Pharmaceutics|January 8, 2025
Model-Based Dose Selection of a Sphingosine-1-Phosphate Modulator, Etrasimod, in Patients with Various Degrees of Hepatic ImpairmentMohammed S Alasmari, Faleh Alqahtani, Fawaz Alasmari, et al.
Pageof 15